by UK Research and Innovation Credit: UK Research and Innovation Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing them to target these proteins for diagnostic tests and treatments. But, in around 10% of cases of frontotemporal dementia, scientists had...